our companies have been featured in
Sort News by Date
- April 2024 1
- March 2024 4
- February 2024 1
- January 2024 1
- December 2023 2
- November 2023 3
- October 2023 1
- September 2023 2
- August 2023 2
- July 2023 1
- June 2023 1
- May 2023 5
- April 2023 2
- March 2023 1
- January 2023 4
- December 2022 1
- November 2022 1
- October 2022 1
- August 2022 4
- June 2022 3
- May 2022 3
- April 2022 2
- March 2022 3
- February 2022 3
- January 2022 6
- December 2021 8
- November 2021 6
- October 2021 3
- September 2021 1
- August 2021 1
- July 2021 2
- June 2021 2
- May 2021 1
- April 2021 1
- March 2021 1
- February 2021 1
- December 2020 2
- November 2020 1
- January 2020 1
- March 2018 1
- October 2016 1
- August 2016 1
Sort News by Company
- Ag Tech Fund 1
- AgTools 1
- Albert 1
- Artio Medical 2
- Asto CT 1
- Backstitch 1
- Blooma 1
- Bonsai Robotics 1
- Breedr 1
- Built In 3
- Cardea Bio 4
- Combyne 1
- Conservation Labs 2
- Consortiex 1
- Daasity 2
- Droneseed 2
- Elate 1
- Evisort 5
- GoSite 1
- Grondex 1
- Hazel Technologies 3
- Helia Care 1
- HerdDogg 2
- Hypercell Technologies 2
- Label Insight 1
- Leo Cancer Care 1
- Lisnr 1
- Mast Reforestation 2
- Myagi 1
- Network Perception 1
- OPER 1
- Opendorse 5
- Paystand 8
- Provision Analytics 1
- Ryvit 1
- Serionix 2
- Serra Capital 3
- Serra Grondex Ag & Food Tech Fund 1
- Serra Ventures 3
- Smart Apply 1
- Swarm Engineering 2
- Tank Utility 1
- Timedoc Health 1
- VerisimLife 6
- Vytelle 4
- WebCareHealth 2
- Wrapify 1
- Zerigo Health 3
Zerigo Health Launches Digital Platform for At-Home Treatment
Zerigo Health, a Serra Capital III portfolio company that has created an at-home smart light therapy solution, made a major announcement this week that it was launching the Zerigo 2.0 ecosystem - a digital platform that connects health care systems and patients to the management and phototherapy treatment of chronic skin conditions such as eczema and psoriasis.
“The American Academy of Dermatology has published guidelines that show phototherapy is safe and effective for psoriasis and eczema,” Frank D. D’Amelio, chief operating officer and interim CEO of Zerigo Health, told Healio. “However, it is really inconvenient for patients to come into the physician’s office two to three times a week for 12 weeks.
To view the full press release, follow here.
Zerigo Health Appoints Helen Calvin as President and Chief Commercial Officer
Zerigo Health, a Serra Capital III portfolio company, announced this week that it has appoint Helen Calvin as the new President and CCO. Helen brings 15+ years of experience in scaling companies across digital health.
Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes. Zerigo’s precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B (NB-UVB) phototherapy, a proven, standard-of-care treatment. Patients benefit from the unique combination of advanced technology with personal coaching and support throughout their treatment journey, which results in documented increases in treatment adherence and patient satisfaction. To learn more, visit www.zerigohealth.com.
Zerigo Health Raises $43 Million in Series B Funding
Zerigo Health, a Serra Capital III portfolio company, announced a $43 million Series B investment on October 21. This funding will drive adoption of the industry’s only connected light therapy solution which is used to treat chronic skin conditions.
To view the full article, follow here.